Bloomberg
Establishing a Drug Pricing Strategy
June 6, 2024
An effective drug pricing strategy requires sustained corporate planning to understand and establish fair pricing in each market where a product is or will be commercialized. This strategy necessarily must include early planning at the development stage, close monitoring of legislative and regulatory pricing reforms in key markets, cross-functional and cross-jurisdictional collaboration across multiple disciplines within an organization, and sensitivity to political sentiment surrounding drug prices. The following checklist outlines high level action items, structural considerations, and substantive issues for pharmaceutical companies and their investors to consider to establish a thoughtful, holistic, and resilient drug pricing strategy for their development programs.
連絡先
得意分野
Suggested News & Insights
Boston Life Sciences RoundtableTuesday, June 9, 2026Most-Favored-Nations Drug Pricing Policy: White House Quietly Releases Report Describing Voluntary MFN DealsMay 29, 2026EU Pharma Package: Compromise Text Published – Best Efforts Required (Part 2)May 18, 2026Most-Favored-Nation Drug Pricing Policy: Executive Actions, Manufacturer Agreements, and Growing Congressional ScrutinyApril 22, 2026Direct-to-Consumer Prescription Drug Platforms: New Government Guidance and Comment OpportunityFebruary 24, 2026Congress Passes Significant Federal Pharmacy Benefit Manager Reform Impacting Pharmaceutical Market AccessFebruary 18, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory

